US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 26.900
  • -0.510-1.86%
Close Feb 25 16:00 ET
  • 26.530
  • -0.370-1.38%
Pre 04:28 ET
3.35BMarket Cap-13.25P/E (TTM)

About Apellis Pharmaceuticals Company

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Company Profile

SymbolAPLS
Company NameApellis Pharmaceuticals
Listing DateNov 9, 2017
Issue Price14.00
Founded2009
CEODr. Cedric Francois, M.D.
MarketNASDAQ
Employees706
Fiscal Year Ends12-31
Address100 5th Avenue
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451-8703
Phone1-617-977-5700
Websitehttp://www.apellis.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Cedric Francois, M.D.
  • Director, Chief Executive Officer and President
  • 10.37M
  • Pascal Deschatelets, PhD
  • Chief Scientific Officer
  • --
  • Dr. Caroline Baumal, M.D.
  • Chief Medical Officer
  • 4.43M
  • Karen Lewis
  • Chief People Officer
  • --
  • Timothy E. Sullivan
  • Chief Financial Officer and Treasurer
  • 3.74M
  • James George Chopas
  • Vice President, Corporate Controller and Chief Accounting Officer
  • --
  • Mark Jeffrey DeLong
  • Chief Business and Strategy Officer
  • --
  • Dr. Jeffrey Eisele, PhD
  • Chief Development Officer
  • --
  • Nur Nicholson
  • Chief Technical Operations Officer
  • --
  • David Acheson
  • Executive Vice President, Commercial
  • --
  • Dr. Gerald L. Chan, Sc.D.
  • Chairman of the Board
  • 504.08K
  • A. Sinclair Dunlop
  • Independent Director
  • 480.96K
  • Paul Fonteyne, M.S.
  • Independent Director
  • 489.08K
  • Keli Walbert
  • Independent Director
  • --
  • Stephanie Monaghan O’Brien
  • Independent Director
  • 488.46K
  • Alec Machiels
  • Independent Director
  • 495.96K
  • David Watson
  • General Counsel
  • 4.89M

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
CG MED EQUIP.
838810
+29.94%
SUZHOUBEARING
430418
+22.35%
4
COCYBER
835207
+21.31%
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
+20.05%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.